AIM Therapeutics Inc.

AIM Therapeutics is a clinical stage company pioneering a new class of non-steroidal, immune modulating, anti-inflammatory drugs for chronic inflammatory conditions. AIM’s proprietary compounds exploit novel discoveries related to powerful natural interactions between the nervous, immune and endocrine systems to treat disease. Effective and potentially safer our commercial product pipeline promises to transform treatment regimes in the multi-billion dollar respiratory markets of asthma and chronic obstructive pulmonary disease [COPD].

647.237.3691
www.aimtherapeutics.com